 |
Your Future in Pharmacy: Attend an Ownership Workshop
You need the right tools to run a stronger business and be a better owner to survive and thrive in today's highly competitive health care marketplace. This proven program is ideal both for those thinking about buying their first pharmacy or opening another. Register now for a 2012 Pharmacy Ownership Workshop, sponsored by McKesson and in part by Pharmacists Mutual. Find out what it takes to own and operate a successful pharmacy. The first workshop is scheduled for Feb. 24-26 in Dallas. Seating is limited to ensure a high degree of personalized learning and interaction. Click here to register. |
 |
Drugs and Treatment
FDA Approves Gilead HIV Drug NDA
Pharmaceutical Business Review (01/19/12)
The new drug application for Gilead Sciences' Viread has been given approval by the FDA. Viread is an oral power co created by Aptalis Pharma and Gilead to treat read more...
Return to Headlines
FDA OKs Drug to Eliminate Chemotherapy Side Effect
Boston Globe (MA) (01/17/12)
The FDA has approved a new drug from BTG International Inc. that helps reduces the amounts of a chemotherapy drug that remains in the bodies of cancer patients. Voraxaze causes read more...
Return to Headlines
Fall Rate Rises Among Those on at Least Two Prescription Drugs
Medical News Today (01/17/12) Rattue, Petra
People who take two or more prescription drugs at any one time, especially drugs that lower blood pressure or cholesterol, have twice the unintentional fall rate at home, researchers have read more...
Return to Headlines
New Colorectal Cancer Drug Shows Promise in Study
Los Angeles Times (CA) (01/17/12) Roan, Shari
Data from a trial of Bayer HealthCare's regorafenib suggests that the drug could extend the life span of patients with advanced colorectal cancer, while slowing tumor growth. The data is from read more...
Return to Headlines
New Drug Combo for Hepatitis C Shows Promise
U.S. News & World Report (01/18/12) Marcus, Mary Brophy
A new cocktail of two investigational drugs appears to have successfully cleared the hepatitis C virus in people who don't respond to standard treatment. Furthermore, the approach seems read more...
Return to Headlines
Study Shows New Drug Helps 'Bridge' Stent Patients to Cardiac Surgery
Medical Xpress (01/17/12)
The Journal of the American Medical Association will be publishing the initial results of a BRIDGE trial of the drug cangrelor. Cangrelor is an investigational intravenous antiplatelet that is designed to read more...
Return to Headlines
Taking the Pill Could Help Ease Menstrual Pain
USA Today (01/18/12)
New research shows that taking the oral contraceptive pill can help ease the cramps, bloating, and other menstrual pain some women experience. These new findings, which add to previous research and read more...
Return to Headlines
|
|
|
Industry News
AstraZeneca and Bristol-Myers Squibb Receive Complete Response Letter From FDA for Dapagliflozin
AstraZeneca Press Release (01/19/12)
AstraZeneca and Bristol-Myers Squibb have announced that the FDA has issued a complete response letter regarding the New Drug Application for investigational compound dapagliflozin for the treatment of read more...
Return to Headlines
Endo Digs in With Groundbreaking on New HQ in Chesco
PennLive (01/19/12)
Pennsylvania Gov. Tom Corbett took a shovel and dug in to break ground for Endo Pharmaceutical’s new headquarters in Atwater, a corporate park on Route 29 in the Great Valley region, that will include read more...
Return to Headlines
Merck Resolves Vioxx Litigation in Canada
Merck Press Release (01/19/12)
Merck has announced that it has entered into an agreement to resolve all claims related to Vioxx in Canada. The agreement was signed by Merck and plaintiffs' representatives and is pending approval by read more...
Return to Headlines
Novo Nordisk Named to FORTUNE'S '100 Best Companies to Work For' List for Fourth Consecutive Year
Novo Nordisk Press Release (01/19/12)
Novo Nordisk has been ranked 43rd in FORTUNE magazine's 2012 "100 Best Companies to Work For" list. The company has been highlighted on the list for four consecutive years. "I'm convinced that read more...
Return to Headlines
Takeda to Cut 10 Percent of Workforce by March 2016
Reuters (01/18/12)
Takeda Pharmaceutical has announced plans to shrink its workforce outside of Japan by around 10 percent by March 2016. The cuts include 700 jobs in the U.S. The pharmaceutical company has been read more...
Return to Headlines
|
|
|
Healthcare Legislation & Regulation and Medicaid/Medicare
CBO: Medicare Cost-Cutting Programs Haven't Worked
TheHill.com (01/18/12) Baker, Sam
The Congressional Budget Office (CBO) has said that programs to cut spending and improve the quality of services provided by Medicare have not been successful. Despite two decades of read more...
Return to Headlines
States Streamline Medicaid Using U.S. Funds to Cut Costs
Bloomberg (01/18/12) Peterson, Molly
A stipulation in the 2010 healthcare law that bans U.S. states from dropping Medicaid patients has forced them to be more efficient in managing the program to save money, according to read more...
Return to Headlines
|
Abstract News © Copyright 2012 INFORMATION, INC.
 |
|
|
FEATURED SPONSOR:
|
|
